The Drug Enforcement Administration ("DEA") announced three new regulations related to the prescription of controlled substances resulting from ...
On January 15, 2025, the Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) issued a series of rules relating ...
The FBI and DEA are investigating these incidents and trying to raise awareness so you don’t fall victim. “Once a criminal ...
The DEA recently released three rules regarding the remote prescribing of controlled substances. However, many telehealth ...
Healthcare executives are calling on the Trump Administration to nullify a DEA proposal to create a special registration for ...
“The proposed registration requirements for telemedicine-based prescribing and dispensing create a new business activity within DEA’s overarching registration framework, distinguishing it from ...
Interest groups responded cautiously to the rules' release. "While we are still digesting the DEA's Special Registration framework ... it is clear that these updates carry significant implications ...
On Wednesday, the DEA released a proposed rule that would set up a special registration process for remote prescribing of Schedule II-V controlled substances such as Xanax, Vicodin and Adderall.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback